Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
銘柄名/コード:
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/05/0619 : 10GlobeNewswire Inc.ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNYSE:ADCTADC Therapeutics SA
2024/05/0619 : 10GlobeNewswire Inc.ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
2024/05/0619 : 06PR Newswire (US)Wine Gift Box Launch Event "When Yantai Meets Bordeaux" Held in Paris to Commemorate 60th Anniversary of Diplomatic Relations between China and France
2024/05/0619 : 05Alliance NewsAlliance NewsEU's Von der Leyen warns China's Xi on "market distorting practices"
2024/05/0619 : 05GlobeNewswire Inc.MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung DiseaseNASDAQ:MNKDMannKind Corporation
2024/05/0619 : 05Business WireAmid High Interest Rates and Inflation, American Homeowners Would Rather Renovate Than Buy a New HomeNYSE:DFSDiscover Financial Services
2024/05/0619 : 02GlobeNewswire Inc.CREDIT AGRICOLE SA : DECLARATION DES DROITS DE VOTE AVRIL 2024BIT:ACACredit Agricole SA
2024/05/0619 : 02GlobeNewswire Inc.CREDIT AGRICOLE SA : DECLARATION DES DROITS DE VOTE AVRIL 2024BIT:1ACACredit Agricole SA
2024/05/0619 : 02GlobeNewswire Inc.CREDIT AGRICOLE SA : DECLARATION DES DROITS DE VOTE AVRIL 2024EU:ACACredit Agricole SA
2024/05/0619 : 02GlobeNewswire Inc.CREDIT AGRICOLE SA : DECLARATION DES DROITS DE VOTE AVRIL 2024TG:XCACredit Agricole SA
2024/05/0619 : 01PR Newswire (Canada)/R E P R I S E -- Avis aux médias - Annonce concernant les investissements routiers 2024-2026 dans la région de Lanaudière/
2024/05/0619 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:KENKenon Holdings Ltd
2024/05/0619 : 00Edgar (US Regulatory)Form 8-K - Current reportNYSE:GLWCorning Inc
2024/05/0619 : 00GlobeNewswire Inc.ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma
2024/05/0619 : 00GlobeNewswire Inc.Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division
2024/05/0619 : 00Business WireCordoniq Scores a Hat-Trick at 2024 Cybersecurity Excellence Awards
2024/05/0619 : 00Business WireNW Natural Holdings Reports First Quarter 2024 ResultsNYSE:NWNNorthwest Natural Holding Company
2024/05/0619 : 00Business WireAmerican Strategic Investment Co. Announces New Leasing, 87.2% OccupancyNYSE:NYCAmerican Strategic Investment Co
2024/05/0619 : 00Business Wire2024 Intel 471 Cyber Threat Report Reveals Emerging Hacktivist and Adversary Strategies in the Cyber Underground
2024/05/0619 : 00Business WireMaxar Intelligence and Lockheed Martin Expand Partnership to Enhance the F-35 Full Mission Simulator Experience
2024/05/0619 : 00Business WireDara Energy, a Production Focused Real Asset Company, Acquires Assets From Vinland Energy, an Appalachia Focused Operator
2024/05/0619 : 00GlobeNewswire Inc.ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone LymphomaNYSE:ADCTADC Therapeutics SA
2024/05/0619 : 00GlobeNewswire Inc.Pulsar Helium Announces Spring Road Restrictions End at Topaz ProjectTSXV:PLSRPulsar Helium Inc
2024/05/0619 : 00GlobeNewswire Inc.AsclepiX Therapeutics Completes Enrollment in DISCOVER Trial for Neovascular Age-Related Macular Degeneration (nAMD)
2024/05/0619 : 00Business WireAccess to Healthcare and Digital Tools Turning a Corner for the Better, According to Providers and PatientsLSE:EXPNExperian Plc
2024/05/0619 : 00GlobeNewswire Inc.USI Insurance Services Acquires Hignojos Insurance Agency
2024/05/0619 : 00GlobeNewswire Inc.Integra LifeSciences Reports First Quarter 2024 Financial ResultsNASDAQ:IARTIntegra LifeSciences Holdings Corporation
2024/05/0619 : 00Business WireSoleo Health Selected as a Specialty Pharmacy Partner of RYPLAZIM® for Plasminogen Deficiency Type 1 (PLGD-1) Treatment
2024/05/0619 : 00Business WireOSARO Appoints Adi Dalvi as VP of Sales, Bolstering Enterprise Robotics Expertise
2024/05/0619 : 00GlobeNewswire Inc.Brains Bioceutical Announces the Addition of Industry Veteran John Boshart to its Animal Health Division

最近閲覧した銘柄